SRS Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tapestry
TPR
|
+$359M |
| 2 |
MongoDB
MDB
|
+$340M |
| 3 |
UnitedHealth
UNH
|
+$151M |
| 4 |
Hims & Hers Health
HIMS
|
+$149M |
| 5 |
CVS Health
CVS
|
+$72.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Spotify
SPOT
|
+$140M |
| 2 |
Atlassian
TEAM
|
+$77.6M |
| 3 |
NVIDIA
NVDA
|
+$72.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$66.1M |
| 5 |
VSXY
Victoria's Secret
VSXY
|
+$37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 41.36% |
| 2 | Consumer Discretionary | 22.05% |
| 3 | Industrials | 20.43% |
| 4 | Healthcare | 8.1% |
| 5 | Technology | 8.06% |
Similar funds
SRS Investment Management's Q1 2025 Portfolio in Review
As of Q1 2025, SRS Investment Management held 27 positions worth $7.46B, up 6% from $7.04B the previous quarter. Its ten largest holdings account for 86% of the portfolio.
SRS Investment Management deployed $778M of net new capital in Q1 2025, opening 7 new positions and adding to 3 existing holdings. Its largest new stake was Tapestry: 4,743,824 shares worth $334M.
By sector, the portfolio is most concentrated in Communication Services at 41% of assets, down from 47% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Spotify, an estimated $140M trimmed.
- SRS Investment Management's largest Q1 2025 buy was Tapestry: 4,743,824 shares worth $334M.
- SRS Investment Management added most to UnitedHealth in Q1 2025, an estimated $151M increase.
- SRS Investment Management's biggest Q1 2025 reduction was Spotify, cutting an estimated $140M.
- SRS Investment Management fully exited NVIDIA in Q1 2025, selling an estimated $72.5M.
- SRS Investment Management's ten largest holdings make up 86% of its $7.46B portfolio in Q1 2025.
- SRS Investment Management opened 7 new positions and closed 4 in Q1 2025.
- SRS Investment Management's portfolio value rose 6% quarter-over-quarter to $7.46B.
Based on SRS Investment Management's 13F filing for Q1 2025, filed 15 May 2025.